EMEA-001900-PIP02-17-M02

Key facts

Active substance
Tralokinumab
Therapeutic area
Dermatology
Decision number
P/0104/2019
PIP number
EMEA-001900-PIP02-17-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of atopic dermatitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
LEO Pharma A/S

Tel. +45 44945888
E-mail: raleodk@leo-pharma.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating